|
Apr 7
|
IBA – ACQUISITION OF OWN SHARES
|
|
Apr 7
|
IBA long-term strategy presented at 2025 Capital Markets Day
|
|
Apr 4
|
IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day
|
|
Apr 3
|
Tri-Service General Hospital in Taiwan to install proton therapy system from IBA
|
|
Feb 11
|
IBA – Transparency Notification IBA SA
|
|
Aug 29
|
IBA Reports Half Year 2024 Results
|
|
Aug 27
|
IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions
|
|
Feb 29
|
IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa
|
|
Feb 13
|
PanTera signs agreement with Bayer for the supply of actinium-225
|
|
Dec 21
|
IBA – Transparency Notification
|
|
Dec 21
|
IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
|
|
Dec 20
|
IBA celebrates a new milestone with the sale of the 100th Cyclone® KIUBE cyclotron
|
|
Dec 5
|
IBA signs research collaboration agreement with the University of Kansas Medical Center on FLASH technology
|
|
Sep 7
|
IBA - Regulated Information
|
|
May 22
|
IBA signs Binding Term Sheet with Medtechnica Ltd for two Proteus®ONE proton therapy solutions at the Tel Aviv Sourasky Medical Center in Israel
|